Skip to main content
. 2017 May 19;16(1):69–74. doi: 10.3892/mmr.2017.6612

Figure 3.

Figure 3.

Knockdown of AB019562 arrests cell cycle at the G0/G1 phase in hepatocellular carcinoma cells. (A) Percentages of siAB019562-treated HepG2 cells in the G0/G1, S and G2/M phases were determined using flow cytometry. *P<0.05 vs. control. (B) Knockdown of AB019562 increased the percentage of SMMC-7721 cells at the G0/G1 phase, but decreased the percentages of cells at the S and G2/M phases. #P<0.05 vs. control. si, small interfering RNA; NC, negative control.